ProKidney Corp. (PROK) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
2000 FRONTIS PLAZA BLVD. WINSTON-SALEM, NC 27103 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 3/31/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | |||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash, cash equivalents, and short-term investments | 60,649,000 | 490,252,000 | 440,488 | |||
| Cash and cash equivalents | 60,649,000 | 490,252,000 | 440,488 | |||
| Prepaid expense | 3,399,000 | 2,624,000 | 504,189 | |||
| Other current assets | 9,000 | 1,384,000 | ||||
| Other undisclosed current assets | 310,089,000 | 10,459,000 | ||||
| Total current assets: | 374,146,000 | 504,719,000 | 944,677 | |||
| Noncurrent Assets | ||||||
| Finance lease, right-of-use asset, after accumulated amortization | 147,000 | 71,000 | ||||
| Operating lease, right-of-use asset | 4,116,000 | 2,285,000 | ||||
| Property, plant and equipment | 42,143,000 | 10,708,000 | ||||
| Intangible assets, net (including goodwill) | 213,000 | |||||
| Intangible assets, net (excluding goodwill) | 213,000 | |||||
| Asset, held-in-trust | 250,008,324 | |||||
| Other undisclosed noncurrent assets | 247,500 | |||||
| Total noncurrent assets: | 46,406,000 | 13,277,000 | 250,255,824 | |||
| TOTAL ASSETS: | 420,552,000 | 517,996,000 | 251,200,501 | |||
| LIABILITIES AND EQUITY | ||||||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts payable and accrued liabilities, including: | 22,763,000 | 10,380,000 | 5,000 | |||
| Accounts payable | 5,098,000 | 3,044,000 | ||||
| Accrued liabilities | 17,665,000 | 7,336,000 | ||||
| Other undisclosed accounts payable and accrued liabilities | 5,000 | |||||
| Debt | 52,000 | 35,000 | ||||
| Due to related parties | ✕ | ✕ | 10,000 | |||
| Other undisclosed current liabilities | 2,223,000 | 458,000 | 1,864,796 | |||
| Total current liabilities: | 25,038,000 | 10,873,000 | 1,879,796 | |||
| Noncurrent Liabilities | ||||||
| Long-term debt and lease obligation | 104,000 | 48,000 | ||||
| Finance lease, liability | 104,000 | 48,000 | ||||
| Liabilities, other than long-term debt | 4,074,000 | 2,136,000 | ||||
| Accounts payable and accrued liabilities | 568,000 | 278,000 | ||||
| Operating lease, liability | 3,506,000 | 1,858,000 | ||||
| Other undisclosed noncurrent liabilities | 7,700,000 | |||||
| Total noncurrent liabilities: | 4,178,000 | 2,184,000 | 7,700,000 | |||
| Total liabilities: | 29,216,000 | 13,057,000 | 9,579,796 | |||
| Temporary equity, carrying amount | 1,494,732,000 | 1,601,555,000 | 250,008,324 | |||
| Equity | ||||||
| Equity, attributable to parent, including: | (1,103,396,000) | (1,096,616,000) | (8,387,619) | |||
| Additional paid in capital | 36,114,000 | 7,476,000 | ||||
| Accumulated other comprehensive income (loss) | 130,000 | |||||
| Accumulated deficit | (1,139,663,000) | (1,104,116,000) | (8,388,308) | |||
| Other undisclosed equity, attributable to parent | 23,000 | 24,000 | 689 | |||
| Total equity: | (1,103,396,000) | (1,096,616,000) | (8,387,619) | |||
| TOTAL LIABILITIES AND EQUITY: | 420,552,000 | 517,996,000 | 251,200,501 | |||
Income Statement (P&L) (USD)
| 3/31/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|---|
| Operating expenses | (151,522,000) | (153,007,000) | |||
| Operating loss: | (151,522,000) | (153,007,000) | |||
| Nonoperating income (Investment Income, Nonoperating) | 22,083,000 | 5,983,000 | |||
| Interest and debt expense | (12,000) | (215,000) | |||
| Loss from continuing operations before income taxes: | (129,451,000) | (147,239,000) | |||
| Income tax expense | (5,996,000) | (896,000) | |||
| Net loss: | (135,447,000) | (148,135,000) | |||
| Net income attributable to noncontrolling interest | 99,979,000 | 40,103,000 | |||
| Other undisclosed net loss attributable to parent | |||||
| Net loss available to common stockholders, diluted: | (35,468,000) | (108,032,000) | |||
Comprehensive Income (USD)
| 3/31/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|---|
| Net loss: | (135,447,000) | (148,135,000) | |||
| Other comprehensive income (loss) | 497,000 | ||||
| Comprehensive loss: | (134,950,000) | (148,135,000) | |||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 99,612,000 | ||||
| Comprehensive loss, net of tax, attributable to parent: | (35,338,000) | (148,135,000) | |||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.